- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Seth H. Lundy
Events 14 results
Conference
September 4, 2025
18th Annual King & Spalding Medical Device Summit
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
October 25, 2023
Nikki Reeves, Seth Lundy, Brian Bohnenkamp to Speak at Pharmaceutical Compliance Congress Conference
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Webinar
April 6, 2017
Managed Care Contracting Risks: An Antitrust, Government Pricing, and Fraud and Abuse Analysis
Conference
January 12, 2017
An Introduction to the 21st Century Cures Act
Conference
July 20, 2016
The New FDA Approach for Expanded Access to Investigational Drugs
Conference
October 20, 2015
Unlevel Playing Field: What Can You Do When Your Competitor Is Gaining An Illegal Advantage?
Conference
September 30, 2015
King & Spalding Medical Device Summit 2015
Conference
June 18, 2015
Navigating the New “Expedited Access Pathway” Program for Medical Devices